Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TechnipFMC (FTI) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for TechnipFMC (FTI) over the last 10 years, with Q3 2025 value amounting to $1.3 billion.

  • TechnipFMC's Cost of Revenue rose 498.71% to $1.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $4.8 billion, marking a year-over-year increase of 1407.18%. This contributed to the annual value of $4.6 billion for FY2024, which is 3479.11% up from last year.
  • TechnipFMC's Cost of Revenue amounted to $1.3 billion in Q3 2025, which was up 498.71% from $1.1 billion recorded in Q2 2025.
  • Over the past 5 years, TechnipFMC's Cost of Revenue peaked at $1.3 billion during Q4 2024, and registered a low of $743.8 million during Q1 2021.
  • Moreover, its 5-year median value for Cost of Revenue was $836.2 million (2023), whereas its average is $931.8 million.
  • Per our database at Business Quant, TechnipFMC's Cost of Revenue tumbled by 1084.31% in 2021 and then skyrocketed by 5387.47% in 2024.
  • TechnipFMC's Cost of Revenue (Quarter) stood at $746.2 million in 2021, then rose by 1.01% to $753.7 million in 2022, then rose by 10.95% to $836.2 million in 2023, then skyrocketed by 53.87% to $1.3 billion in 2024, then decreased by 2.16% to $1.3 billion in 2025.
  • Its Cost of Revenue was $1.3 billion in Q3 2025, compared to $1.1 billion in Q2 2025 and $1.1 billion in Q1 2025.